USPTO serial 97121020
NKMAX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 22, 2023
- Examiner
- COGAN, BRITTNEY LORRAINE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NKMAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gyeonggi-do, KR
Gyeonggi-do, KR
Gyeonggi-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Deborah L. Corpus
Deborah L. Corpus Chrisman Gallo Tochtrop LLC6509 Brecksville Road #31550Independence, OH 44131United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for animals for regulating the immune system and treating cancer; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells for regulating the immune system and treating cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders | ACTIVE | Aug 5, 2019 |
| 042 | Development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology products; biotechnological research; cell separation research services; technological research in the field of cell therapy, medicine, pharmacology, biotechnology | ACTIVE | Mar 5, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 6, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 6, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 6, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 22, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 22, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 18, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 17, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 17, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 27, 2023 | IUAF | USE AMENDMENT FILED | — |
| Apr 27, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 20, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 25, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 25, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 5, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 19, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 25, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 25, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 25, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 15, 2021 | NWAP | NEW APPLICATION ENTERED | — |